BAP1 Loss Results in Cell Cycle Dysregulation and Increased Proliferation in Clear Cell Renal Cell Carcinoma

被引：0
|
作者：
Kapur, P. [1 ]
Christie, A. [1 ]
Pena-Llopis, S. [1 ]
Margulis, V. [1 ]
Lotan, Y. [1 ]
Xie, X-J [1 ]
Brugarolas, J. [1 ]
机构：
[1] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
来源：
LABORATORY INVESTIGATION | 2013年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
924
引用
收藏
页码：223A / 223A
页数：1
相关论文
共 50 条
  • [31] ADVERSE OUTCOMES IN CLEAR CELL RENAL CELL CARCINOMA WITH MUTATIONS OF EPIGENETIC REGULATORS BAP1 AND SETD2
    Hakimi, A. Ari
    Ostrovnaya, Irina
    Reva, Boris
    Schultz, Nikolaus
    Chen, Ying-Bei
    Gonen, Mithat
    Liu, Han
    Takeda, Shugaku
    Tickoo, Satish K.
    Voss, Martin H.
    Cheng, Emily H.
    Reuter, Victor E.
    Motzer, Robert J.
    Russo, Paul
    Hsieh, James J.
    [J]. JOURNAL OF UROLOGY, 2013, 189 (04): : E438 - E438
  • [32] PBRM1 and BAP1 expression in renal cell carcinoma
    Kuthi, L.
    Fallmann, E.
    Jenei, A.
    Posfai, B.
    Maraz, A.
    [J]. VIRCHOWS ARCHIV, 2018, 473 : S44 - S44
  • [33] Clinicopathologic Features of Clear Cell Renal Cell Carcinomas with Loss of Nuclear BAP1 Expression: A Multi-Institutional Study
    Czaja, Rebecca
    Tripathy, Anusmita
    Zalles, Nicole
    Williamson, Sean
    Antic, Tatjana
    Gallan, Alexander
    [J]. LABORATORY INVESTIGATION, 2023, 103 (03) : S703 - S704
  • [34] Concomitant Loss of PBRM1 and BAP1 Protein Expression is an Important Prognostic Event in Early Stages of Clear Cell Renal Cell Carcinoma.
    da Cunha, Isabela W.
    da Costa, Walter H.
    Fares, Aline F.
    Bezerra, Stephania M.
    Schultz, Luciana
    Guimaraes, Gustavo C.
    Zequi, Stenio C.
    [J]. MODERN PATHOLOGY, 2018, 31 : 336 - 336
  • [35] PBRM1, SETD2 and BAP1 — the trinity of 3p in clear cell renal cell carcinoma
    Joseph Walton
    Keith Lawson
    Panagiotis Prinos
    Antonio Finelli
    Cheryl Arrowsmith
    Laurie Ailles
    [J]. Nature Reviews Urology, 2023, 20 : 96 - 115
  • [36] Prognostic value of BAP1 expression in clear cell renal cell carcinoma with inferior vena cava tumor thrombosis.
    Oka, Suguru
    Inoshita, Naoko
    Miura, Yuji
    Oki, Ryosuke
    Miyama, Yu
    Nagamoto, Shoichi
    Ogawa, Kohei
    Sakaguchi, Kazushige
    Kondoh, Chihiro
    Kurosawa, Kazuhiro
    Urakami, Shinji
    Takano, Toshimi
    Okaneya, Toshikazu
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [37] The critical role of BAP1 mutation in the prognosis and treatment selection of kidney renal clear cell carcinoma
    Tan, Guobin
    Xuan, Zijun
    Li, Zhiqin
    Huang, Shuitong
    Chen, Guangming
    Wu, Yonglu
    Chen, Xianxi
    Liang, Zhijin
    Wu, Aiming
    [J]. TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (04) : 1725 - 1734
  • [38] BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor
    Jeanette E. Eckel-Passow
    Daniel J. Serie
    John C. Cheville
    Thai H. Ho
    Payal Kapur
    James Brugarolas
    R. Houston Thompson
    Bradley C. Leibovich
    Eugene D. Kwon
    Richard W. Joseph
    Alexander S. Parker
    [J]. BMC Urology, 17
  • [39] BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor
    Eckel-Passow, Jeanette E.
    Serie, Daniel J.
    Cheville, John C.
    Ho, Thai H.
    Kapur, Payal
    Brugarolas, James
    Thompson, R. Houston
    Leibovich, Bradley C.
    Kwon, Eugene D.
    Joseph, Richard W.
    Parker, Alexander S.
    [J]. BMC UROLOGY, 2017, 17 : 1 - 7
  • [40] The loss of BAP1 protein expression predicts poor prognosis in patients with nonmetastatic clear cell renal cell carcinoma with inferior vena cava tumor thrombosis
    Oka, Suguru
    Inoshita, Naoko
    Miura, Yuji
    Oki, Ryosuke
    Miyama, Yu
    Nagamoto, Shoichi
    Ogawa, Kohei
    Sakaguchi, Kazushige
    Kondoh, Chihiro
    Kurosawa, Kazuhiro
    Urakami, Shinji
    Takano, Toshimi
    Okaneya, Toshikazu
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (08) : 365.e9 - 365.e14
12345